《European Journal of Nuclear Medicine and Molecular Imaging,2月14日,Imaging features of 2019 novel coronavirus pneumonia》

  • 来源专题:COVID-19科研动态监测
  • 编译者: dingxq
  • 发布时间:2020-02-16
  • Imaging features of 2019 novel coronavirus pneumonia

    Xi Xu, Chengcheng Yu, Lieguang Zhang, Liangping Luo & Jinxin Liu

    DOI:https://doi.org/10.1007/s00259-020-04720-2

    Recently, a type of pneumonia caused by a novel Betacoronavirus, the 2019 novel coronavirus (2019-nCoV), has spread in China, mainly in Wuhan [1]. It is known that cases of this disease have also been identified in other provinces of China [2].

    A 53-year-old man has lived in Wuhan for many years, and recently came to Guangzhou, China. He was admitted to the hospital with fever and cough in the last 2 days, and his highest body temperature was 38.3 °C before admission. The laboratory examinations showed decreased white blood cell count (2.50 × 109/L) and elevated C-reactive protein (16.2 mg/L; normal range 0–10 mg/L).

    Non-contrast-enhanced chest computed tomography (CT) (Fig. 1a, b) showed multiple, bilateral, peripheral, patchy ground glass opacities, lobular, and subsegmental, with fading margins. The lesions had mainly a subpleural distribution.

    CT also demonstrated slight thickening of the adjacent pleura (yellow arrow) and interlobular septa in the lesion (red arrow). Subsequently, the patients had laboratory-confirmed 2019-nCoV infection by real-time polymerase chain reaction (PCR). After 5 days, CT scan (Fig. 1c, d) showed enlarged lesions, compared with previous images, and progressive ground glass opacities in both lower lobes, indicating disease progression.

    Infection with 2019-nCoV was confirmed based on the patient’s epidemiological history, clinical manifestations, imaging characteristics, and laboratory tests.

    Bilateral, multiple, patchy, or ground glass opacities, with subpleural distribution, were the lung CT appearances of this patient, affected by 2019-nCoV pneumonia. These characteristics should be recognized by professionals working in imaging departments.

  • 原文来源:https://link.springer.com/article/10.1007%2Fs00259-020-04720-2
相关报告
  • 《EJNMMI,2月28日,Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-01
    • Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2 Xi Xu, Chengcheng Yu, Jing Qu, Lieguang Zhang, Songfeng Jiang, Deyang Huang, Bihua Chen, Zhiping Zhang, Wanhua Guan, Zhoukun Ling, Rui Jiang, Tianli Hu, Yan Ding, Lin Lin, Qingxin Gan, Liangping Luo, Xiaoping Tang & Jinxin Liu European Journal of Nuclear Medicine and Molecular Imaging (2020) Abstract Background The pneumonia caused by the 2019 novel coronavirus (SARS-CoV-2, also called 2019-nCoV) recently break out in Wuhan, China, and was named as COVID-19. With the spread of the disease, similar cases have also been confirmed in other regions of China. We aimed to report the imaging and clinical characteristics of these patients infected with SARS-CoV-2 in Guangzhou, China.
  • 《Radiology,2月4日,CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-06
    • CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) Michael Chung, Adam Bernheim, Xueyan Mei, Ning Zhang, Mingqian Huang, Xianjian Zeng, Jiufa Cui, Wenjian Xu, Yang Yang, Zahi Fayad, Adam Jacobi, Kunwei Li, Shaolin Li, Hong Shan Published Online:Feb 4 2020https://doi.org/10.1148/radiol.2020200230 Abstract In this retrospective case series, chest CT scans of 21 symptomatic patients from China infected with the 2019 Novel Coronavirus (2019-nCoV) were reviewed with emphasis on identifying and characterizing the most common findings. Typical CT findings included bilateral pulmonary parenchymal ground-glass and consolidative pulmonary opacities, sometimes with a rounded morphology and a peripheral lung distribution. Notably, lung cavitation, discrete pulmonary nodules, pleural effusions, and lymphadenopathy were absent. Follow-up imaging in a subset of patients during the study time window often demonstrated mild or moderate progression of disease as manifested by increasing extent and density of lung opacities.